Skip to content
About us
Mission & Strategy
Our story
Our team
Inobrodib
Science
Clinical trials
Indications under investigation
For Physicians
For Patients
News
Press releases
Publications
Contact us
About us
Mission & Strategy
Our story
Our team
Inobrodib
Science
Clinical trials
Indications under investigation
For Physicians
For Patients
News
Press releases
Publications
Contact us
Linkedin
Latest press releases
View all
CellCentric expands executive team with new Chief Strategy Officer
13 January 2025
Press Release
CellCentic Presents Latest Clinical Data at ASH: Promising Efficacy and Safety in Multiple Myeloma
10 December 2024
Press Release
CellCentric to Share Latest Inobrodib Phase II Data; Oral Presentation at ASH 2024
6 November 2024
Press Release
Inobrodib
A first-in-class oral
anti-cancer drug
Find out more
Main Menu
About us
Mission & Strategy
Our story
Our team
Inobrodib
Science
Clinical trials
Indications under investigation
For Physicians
For Patients
News
Press releases
Publications
Contact us
Follow us on LinkedIn
